He is doctor in Medicine, post-graduated in Biostadistics and associated professor at the Universitat de Barcelona. Currently, he is also the Clinical Director of the Thoracic area of Hospital Germans Trias I Pujol. Moreover, he is a researcher at CIBER Pulmonology group of respiratory diseases.
He supervises several research projects at Institute Carlos III and, other public institutions and international journals. Regarding his academic career, he has published more than 10 scientific articles with high impact factor and developed 3 patents.
He is doctor in Medicine and Surgery and post-graduated in Health Services. He was President of the European Society of Cardiac Arrythmias and Medical Director of the Hospital Clínic de Barcelona. Currently, he is chairman of Cardiology at University of Barcelona and Director of Pediatric Arrythmias Unit at Hospital Sant Joan de Déu.
He leads the 2.2 IDIBAPS research group, focusing on the study of mechanisms and treatments of cardiac arrythmias. Regarding his academic career, he has published more than 450 scientific articles with high impact factor and coordinated several research projects.
He was Head of Safety and Efficacy at the European Medicines Agency (EMA) during 2005-2012, and previously held leadership positions in the biopharmaceutical industry covering international clinical development, biostatistics and medical affairs.
He has developed expertise in several specific therapeutic areas and carried out postgraduate qualification in clinical pharmacology, drug development and regulation.
As independent consultant he provides strategic for regulatory plans in Europe.
He is a Telecommunication Engineer by Univeristat Politècnica de Catalunya, where he focused in Electronics.
Currently, he is Director of Tecno-Med Engineers, consultancy for the application of the requirements of the Medical Devices. He has a vast experience in classification of medical devices and the establishment of Quality Management Systems. He is also vice-president of the Spanish Society of Electromedicine and Clinical Engineering since 2013.
He is independent consultor
expertized in Biopharmaceutical
He has worked for Rubió Laboratories as Senior Consultor and he was also member of the Executive Committee. Previously, he worked at Almirall S.A, overseeing the development of projects and licenses.
He has also worked as
Neuropathologist at Hospital Nostra Senyora del
Mar. His vast experience in consulting and networking at EE.UU, Japan and Europe, evidences his leading and supervising skills.
He is a private investor in health and real estate companies and he also develops consultancy
projects for Adequita.
In the past, and focused in the
Consumer Health market, Pau
has successfully created product portfolios, entered and
developed new international
markets, building value
companies through brands. He
is an expert in Strategical
He is co-funder of IHT, Spanish company for the development and commercialization of biomedical devices, among other 15 companies.
As one of the pioneers in the Spanish biomedical sector, he has participated in the development and launch of several projects, counting on the development, manufacture and international launch of more than 50 products. Specializing in minimally invasive products such as intravascular cardiac prostheses and delivery systems among others.